4//SEC Filing
Eliya Yehuda 4
Accession 0001213900-25-023367
CIK 0001415397other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:51 PM ET
Size
8.1 KB
Accession
0001213900-25-023367
Insider Transaction Report
Form 4
Eliya Yehuda
Director
Transactions
- Award
Warrant to purchase Common Stock
2025-03-10+200,000→ 200,000 totalExercise: $1.00Exp: 2026-03-10→ Common Stock (200,000 underlying) - Expiration
Warrant to purchase Common Stock
2022-05-12−202,000→ 0 totalExercise: $1.12Exp: 2024-05-12→ Common Stock (202,000 underlying)
Footnotes (2)
- [F1]200,000 warrants to purchase Common Stock of the issuer were received as compensation for the reporting person's service as a director of the issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 10, 2025. The Warrants are exercisable immediately and will expire on March 10, 2026.
- [F2]202,000 warrants to purchase Common Stock of the issuer expired on May 12, 2024, and are no longer beneficially owned by the reporting person.
Documents
Issuer
Raphael Pharmaceutical Inc.
CIK 0001415397
Entity typeother
Related Parties
1- filerCIK 0001904163
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:51 PM ET
- Size
- 8.1 KB